Position in ERAS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$27,532,257
+$22,579,048 QoQ
Shares Held
1,701,623
+27.8% QoQ
Ownership
0.547%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 98.25942644169713.ToString("F0")%
Shared 1.7405735583028672.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ERAS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026NORTHERN TRUST CORP holds $6,613,834,361 across 418 Biotechnology names. ERAS ranks #48 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,564,264 | $1,145,046,441 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
941,941 | $727,781,290 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
858,120 | $283,926,160 | |
| 4 | INSM |
INSMED Inc
|
1,294,000 | $211,594,876 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,808,735 | $182,705,014 | |
| 6 | INCY |
Incyte Corp
|
1,849,726 | $174,096,208 | |
| 7 | MRNA |
Moderna, Inc.
|
2,952,041 | $149,963,680 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,403,642 | $104,234,453 |
All Filings in ERAS
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $27,532,257 | 1,701,623 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $4,953,209 | 1,331,508 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $3,146,852 | 1,443,511 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $1,791,997 | 1,411,022 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $2,282,156 | 1,665,809 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $4,309,942 | 1,717,109 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $4,198,599 | 1,537,949 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $2,014,591 | 853,641 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,364,720 | 662,486 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,492,952 | 700,917 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,414,664 | 718,105 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,917,530 | 694,758 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,975,418 | 656,286 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,492,285 | 578,257 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $4,250,047 | 544,878 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,681,998 | 481,508 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $4,086,125 | 475,131 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,943,139 | 188,905 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $3,877,084 | 182,709 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||